Real-time Stock quotes, portfolio, LIVE TV and more.
0.4 (0.14%)
0.7 (0.25%) 10.31 am | 14 Feb 2013 | Source: CNBC-TV18
Biocon, a global biopharmaceutical enterprise today entered into a licencing agreement with Mylan for three bio-generic insulin products. Kiran Mazumd...